Moderna in talks with South Korea to supply 40 million doses of Covid-19 vaccine

Biotechnology company Moderna is negotiating with the South Korean government to potentially provide 40 million or more doses of its vaccine against Covid-19.

Under the terms of the proposed agreement, the company will commence distribution of the vaccine in the second quarter of 2021.